key: cord-0749461-d9u1t9i9
authors: Naleway, Allison L.; Grant, Lauren; Caban‐Martinez, Alberto J.; Wesley, Meredith G.; Burgess, Jefferey L.; Groover, Kimberly; Gaglani, Manjusha; Yoon, Sarang K.; Tyner, Harmony L.; Meece, Jennifer; Kuntz, Jennifer L.; Yoo, Young M.; Schaefer‐Solle, Natasha; Olsho, Lauren E. W.; Gerald, Joe K.; Rose, Spencer; Thiese, Matthew S.; Lundgren, Jessica; Groom, Holly C.; Mak, Josephine; Louzado Feliciano, Paola; Edwards, Laura J.; Lutrick, Karen; Dunnigan, Kayan; Phillips, Andrew L.; Lamberte, Julie Mayo; Noriega, Roger; Sokol, Brian E.; Odean, Marilyn; Ellingson, Katherine D.; Smith, Michael; Hegmann, Kurt T.; Respet, Karley; Dickerson, Monica; Cruz, Alexandra; Fleary, Deanna E.; Murthy, Kempapura; Hunt, Angela; Azziz‐Baumgartner, Eduardo; Gallimore‐Wilson, Damena; Harder, Jenna A.; Odame‐Bamfo, Leah; Viergutz, Jennifer; Arvay, Melissa; Jones, John M.; Mistry, Peenaz; Thompson, Mark G.; Fowlkes, Ashley L.
title: Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 2021
date: 2022-01-13
journal: Influenza Other Respir Viruses
DOI: 10.1111/irv.12956
sha: 276678bb624406a66aeb4f42ede072fa7c5e9b7f
doc_id: 749461
cord_uid: d9u1t9i9

BACKGROUND: We sought to evaluate the impact of changes in estimates of COVID‐19 vaccine effectiveness on the incidence of laboratory‐confirmed infection among frontline workers at high risk for SARS‐CoV‐2. METHODS: We analyzed data from a prospective frontline worker cohort to estimate the incidence of COVID‐19 by month as well as the association of COVID‐19 vaccination, occupation, demographics, physical distancing, and mask use with infection risk. Participants completed baseline and quarterly surveys, and each week self‐collected mid‐turbinate nasal swabs and reported symptoms. RESULTS: Among 1018 unvaccinated and 3531 fully vaccinated workers, the monthly incidence of laboratory‐confirmed SARS‐CoV‐2 infection in January 2021 was 13.9 (95% confidence interval [CI]: 10.4–17.4), declining to 0.5 (95% CI ‐0.4‐1.4) per 1000 person‐weeks in June. By September 2021, when the Delta variant predominated, incidence had once again risen to 13.6 (95% CI 7.8–19.4) per 1000 person‐weeks. In contrast, there was no reportable incidence among fully vaccinated participants at the end of January 2021, and incidence remained low until September 2021 when it rose modestly to 4.1 (95% CI 1.9–3.8) per 1000. Below average facemask use was associated with a higher risk of infection for unvaccinated participants during exposure to persons who may have COVID‐19 and vaccinated participants during hours in the community. CONCLUSIONS: COVID‐19 vaccination was significantly associated with a lower risk of SARS‐CoV‐2 infection despite Delta variant predominance. Our data demonstrate the added protective benefit of facemask use among both unvaccinated and vaccinated frontline workers.

incidence had once again risen to 13.6 (95% per 1000 person-weeks. In contrast, there was no reportable incidence among fully vaccinated participants at the end of January 2021, and incidence remained low until September 2021 when it rose modestly to 4.1 (95% CI 1.9-3.8) per 1000. Below average facemask use was associated with a higher risk of infection for unvaccinated participants during exposure to persons who may have COVID-19 and vaccinated participants during hours in the community.

Conclusions: COVID-19 vaccination was significantly associated with a lower risk of SARS-CoV-2 infection despite Delta variant predominance. Our data demonstrate the added protective benefit of facemask use among both unvaccinated and vaccinated frontline workers. (VE) declined to 66% during B.1.617.2 (Delta) predominance. [1] [2] [3] [4] [5] Changes in COVID-19 VE estimates associated with changes in predominating variant virus circulation over time may have important implications for infection risk in work and community settings. Particularly at increased risk of SARS-CoV-2 infection are frontline workers, including healthcare personnel, first responders, and essential and other frontline workers who provide direct care and services to the public. Using data from the CDC HEROES-RECOVER Network, a prospective frontline worker cohort, we examined changes in the monthly incidence of COVID-19 by vaccination status, as well as the association of additional factors of occupation, demographics, physical distancing, and mask use with risk of infection. Here, we demonstrate that COVID-19 vaccines dramatically reduced the risk of any SARS-CoV-2 infection among vaccinated adults at high occupational risk of exposure, and substantial protection continues to be evident despite the high prevalence of the Delta variant during recent months. defined as ≥1 symptom of fever, chills, cough, shortness of breath, sore throat, diarrhea, muscle aches, or change in smell or taste. 6, 7 As rotating questions in weekly surveys, participants reported hours in the past 7 days of direct contact (within 3 ft.) and associated percentage facemask use with people at work, in the community, or in any setting who may have COVID-19. Hours of direct contact and percent facemask use were summarized as monthly averages, and then each week was categorized as above or below the corresponding monthly average. Participants self-collected a mid-turbinate nasal swab each week and at the onset of CLI for SARS-CoV-2 testing by reverse transcription-polymerase chain reaction (RT-PCR) and genomic sequencing, if positive. COVID-19 vaccinations were documented through vaccine cards, electronic medical records, or state immunization registries. Participants were considered fully vaccinated ≥14 days after a second mRNA COVID-19 vaccine dose or a single Johnson & Johnson's Janssen vaccine dose; unvaccinated participants had no COVID-19 vaccine receipt. Indeterminate vaccination status was defined from one day following a COVID-19 vaccine dose until the participant was fully vaccinated and was excluded from analysis. Participants provided informed consent for study activities, and the study protocol was reviewed and approved by institutional review boards at all participating sites, including Abt Associates and CDC.

From January to September 2021, participants with no prior SARS-CoV-2 infection contributed unvaccinated or fully vaccinated person-time according to standard definitions until SARS-CoV-2 detection, study withdrawal, or the end of the study period. Monthly unadjusted incidence was calculated as the number of infections relative to the observed person-weeks, and 95% Wald confidence intervals were estimated. To examine factors associated with SARS-CoV-2 incidence during the entire observation period stratified by vaccination status, we used stratified Poisson generalized estimating equations to account for repeated measures. 8 Each model had the factor of interest as the independent variable, log weeks of exposure as an offset, and participants repeating with an independent correlation structure. Statistical significance was defined as a two-tailed pvalue < 0.05. A final model examined incidence by vaccination status, T A B L E 1 Characteristics of health care personnel, first responders, and other essential and frontline workers with reverse transcriptionpolymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infections and percentage receiving one or more doses of COVID vaccine-January-September 2021 

adjusted for factors significantly associated with infection in univariate analysis, including site, occupation, and reported direct contact and facemask use. All analyses were conducted using SAS Version 9.4

and graphics created using R Version 4.1.

Among 4549 participants, 1020 (22%) were unvaccinated, and 3529

(78%) were fully vaccinated by the end of the observation period ( shown). The frequency in which a participant's report was higher or lower than the average is given in Table 1 .

Frequency of SARS-CoV-2 infections varied by site and was significantly higher among participants who were male, first responders, and reported lower than average facemask use ( Occupation categories: primary HCP (physicians, physician assistants, nurse practitioners, dentists), other allied HCP (nurses, therapists, technicians, medical assistants, orderlies, and all others providing clinical support in inpatient or outpatient settings), first responders (firefighters, law enforcement, corrections, emergency medical technicians), essential and other frontline workers (workers in hospitality, delivery, and retail; teachers; all other occupations that require contact within 3 ft. of the public, customers, or coworkers as a routine part of their job). d Chronic conditions included asthma; other chronic lung disease, such as COPD, emphysema; cancer; diabetes; heart disease or condition; hypertension or high blood pressure; immunosuppression; kidney disease; liver disease; neurologic or neuromuscular disease or disorder; and autoimmune disease. For 135 participants, who did not respond to the self-report question, they were imputed as none, pending further verification. e Each week, participants were asked to report hours of direct contact (within 3 ft.) of others and percent of these hours wearing a facemask in the past 7 days in one of the following scenarios: with persons who have confirmed or suspected COVID-19, people at work, or people in the community. f For individual questions, denominators vary due to missing information: Participants may have withdrawn prior to answering, newer enrollees may not have received the question at the time of this analysis, or participants may choose not to answer. and greater use of facemasks with others at work and in the community (Table 1 ).

Monthly incidence rates with 95% confidence intervals were plotted for unvaccinated and vaccinated adults during January to September 2021 ( Figure 1 ). Among unvaccinated adults, incidence rates had a W-shaped trend with the highest incidence of 

In a prospective cohort of frontline workers, the risk of SARS-CoV-2 infection, regardless of symptoms, was four times higher for unvaccinated adults ( The findings in this study are subject to four key limitations. First, the HEROES-RECOVER participants represent a highly vaccinated population relative to the general population, and the person-time contribution of unvaccinated participants is diminished and may not F I G U R E 1 Monthly incidence * of SARS-CoV-2 among unvaccinated and fully COVID-19 vaccinated frontline workers-January-September 2021. The unadjusted incidence was calculated for each month as the number of infections relative to the observed person-weeks, and 95% confidence intervals were estimated using Wald intervals T A B L E 2 Incidence a of SARS-CoV-2 infection among unvaccinated and fully COVID-19 vaccinated frontline workers by sociodemographic and behavioral factors-January-September 2021 Unadjusted cumulative incidence was calculated as the number of cases relative to the observed person-weeks using stratified Poisson generalized estimating equations to account for repeated measures. b Occupation categories: primary HCP (physicians, physician assistants, nurse practitioners, dentists), other allied HCP (nurses, therapists, technicians, medical assistants, orderlies, and all others providing clinical support in inpatient or outpatient settings), first responders (firefighters, law enforcement, corrections, emergency medical technicians), essential and other frontline workers (workers in hospitality, delivery, and retail; teachers; all other occupations that require contact within 3 ft. of the public, customers or coworkers as a routine part of their job). c Each week, participants were asked to report hours of direct contact (within 3 ft.) of others and percent of these hours wearing a facemask in the past 7 days in one of the following scenarios: with persons who have confirmed or suspected COVID-19, people at work, or people in the community.

Allison Naleway: Conceptualization; data curation; investigation

Formal analysis; investigation; methodology. Alberto Caban-Martinez: Data curation; investigation. Meredith Wesley: Data curation; formal analysis; investigation. Jefferey Burgess: Conceptualization; data curation; investigation. Kimberly Groover: Data curation; investigation. Manjusha Gaglani: Conceptualization

data curation; investigation. Harmony Tyner: Conceptualization; data curation; investigation. Jennifer Meece: Data curation; investigation

Data curation; investigation. Young Yoo: Formal analysis; investigation; methodology. Natasha Schaefer-Solle: Data curation; investigation. Lauren Olsho: Conceptualization; investigation; methodology. Joe Gerald: Data curation; investigation. Spencer Rose: Data curation

Data curation; investigation. Holly Groom: Data curation; investigation

Paola Feliciano: Data curation; investigation. Laura Edwards: Data curation; investigation. Karen Lutrick: Data curation

Kayan Dunnigan: Data curation; investigation. Andrew Phillips: Data curation; investigation. Marilyn Odean: Data curation

Conceptualization; investigation; methodology. Ashley Fowlkes: Conceptualization; investigation; methodology. CONFLICT OF INTEREST All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Allison L. Naleway reported institutional funding from Pfizer and Vir Biotechnology for studies unrelated to the submitted work and Jennifer Kuntz receives research funding from Pfizer, Novartis, and Vir Biotechnology for unrelated studies. Matthew S. Thiese reports grants and personal fees from Reed Group and the American College of Occupational and Environmental Medicine, outside the submitted work. No other potential conflicts of interest were disclosed. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. PEER REVIEW The peer review history

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request

Manjusha Gaglani

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (delta) variant predominanceeight U.S. locations

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Safety and efficacy of singledose Ad26.COV2.S vaccine against Covid-19

Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines

Research on the epidemiology of SARS-CoV-2 in essential response personnel (RECOVER) study: protocol for a multi-site longitudinal cohort

COVID-19 infection, reinfection, and vaccine effectiveness in a prospective cohort of Arizona frontline/essential workers: the AZ HEROES research protocol

Longitudinal data analysis using generalized linear models

Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status -13

New COVID-19 cases and hospitalizations among adults, by vaccination status

Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations